This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): PF-04965842
Description: PF-04965842 is an orally administered Janus kinase 1 (JAK1) inhibitor. JAK1 is a membrane-associated phosphoprotein involved in the interferon-alpha, -beta, and -gamma signal transduction pathways.
Additional information available to subscribers only: